U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07428746) titled 'Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes' on Feb. 17.
Brief Summary: The goal of this study is to learn how GLP-1 receptor agonist therapy affects muscle and bone health in older females over age 65 with type 2 diabetes.
The main question it aims to answer is whether or not 6 months of GLP-1 RA therapy affects muscle strength.
Participants will:
* Receive GLP-1 RA therapy as part of their routine clinical care
* Complete muscle strength assessments (hand grip strength, Timed Up and Go test)
* Provide blood samples for bone turnover markers
* Undergo bone mineral densi...